| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 |
| filingDate |
1992-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ac56a3bee64af89606ae75f885c7fdc |
| publicationDate |
1995-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5441737-A |
| titleOfInvention |
Use of apotransferrin that has bound zinc or copper ions for treatment of toxic effects of endotoxins |
| abstract |
Apotransferrin bound to zinc or copper is administered to a patient who has endotoxins present in the patient's bloodstream. The apotransferrin improves the elimination of endotoxins from the bloodstream. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005048125-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7138113-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6864231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1222919-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002132761-A1 |
| priorityDate |
1991-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |